When considering early-stage investment opportunities, many investors emphasize the team over the business opportunity, i.e., they bet on the jockey more than the horse. However, in the realm of life science startup...
In the ever-evolving healthcare landscape, technological innovations continue to drive significant advancements. In this article, we delve into the realm of medical device investment, exploring key trends,...
In the past year, we saw great achievements across our portfolio of high-impact life science companies despite a challenging overall fundraising environment. Our VIC Tech team and the portfolio company teams showed...
In healthcare, a paradigm shift is underway – one that promises to transform healthcare as we know it. The emergence of personalized medicine, fueled by groundbreaking advancements in genomics and diagnostics, can save...
Within the VIC Tech portfolio, SFC Fluidics and Solenic Medical have both announced FDA Breakthrough Device designation. But what is FDA Breakthrough Device designation and what benefits does it provide? From a...
In the world of early stage investing, traditional venture capital funds have long been the go-to option for investors seeking exposure to high-growth opportunity companies. However, a different investment model is...
Investing in a life science startup can be a lucrative opportunity, but it requires careful evaluation to weigh the potential reward against the level of risk. Members of VIC Tech's affiliated VIC Investor Network...
As CEO of VIC Tech, I am fortunate to have the opportunity to review exciting new life science technologies on an ongoing basis and regularly speak with life science thought leaders, inventors, investors, and large...
Dramatic life science advancements are emerging that are likely to transform healthcare over the next 20 years. For example, continued rapid progress of cell and gene therapies will offer a complete cure for a wide...
In my last article, I discussed why individual investors should include privately held, innovation-driven companies in a diversified and balanced investment strategy [Seven Reasons Venture Capital-Stage Companies Should...
FEATURED RESOURCES
